Idinvest Partners, a leading investor in SMEs across Europe, today announces the appointment of Nicolas Debock as Investment Director in the Venture Capital team.

Bowmark Capital, the mid-market private equity firm, has backed the buy-out of The Instant Group, a global leader in independent flexible workspace solutions.   

Founded in 1999, Instant provides alternative methods of office procurement and management, with specific focus on flexible workspace and medium-term lease solutions, employing 250 people in 11 cities around the world.

Browne Jacobson’s corporate team has advised on another InsurTech venture capital deal – assisting crowd insurance pioneer Laka on its £1.1m (US $1.5m) seed round. The round was led by Tune Protect Group Berhad (Tune Protect), a financial holding company listed on the Malaysian Stock Exchange. Silicon Valley-based venture capital firm 500 Startups also participated, alongside new and existing angel investors from across the insurance industry.

Zebra Medical Vision, the leading machine and deep learning startup, is announcing today it has raised $30M in C round funding, bringing the total investment in the company to $50M. In addition, the company is unveiling its Textray chest x-ray research today, the most comprehensive AI research conducted on chest x-rays to date, which provides a glimpse into a future automated chest x-ray analysis product being developed by the company.

Venture capital fund Downing Ventures has participated in a £4 million Series A1 funding round for Cambridge Touch Technologies Limited (CTT).

Spun out of the University of Cambridge in 2011, CTT is a leading developer of AI-powered 3D touch technologies that can be used across a wide range of smart devices, from smartphones and tablets to automotive and industrial technologies.

SIS Ventures is launching its first £5 million fund to back Scotland’s high impact enterprises.

Benefiting from both Enterprise Investment Scheme (EIS) relief and Social Investment Tax Relief (SITR), Impact First will offer investors a portfolio of between six and twelve high-growth potential, high-impact enterprises which aim to tackle a clearly identifiable social problem with a scalable and disruptive business solution.

MediSieve Ltd, the team behind an innovative blood filtration device, are happy to announce the company has received over £1.75 million in funding.

The cash influx has come from a mix of both old and new investors – reflecting the growing confidence in the potential of the device. The medical device company is best known for their magnetic blood filtration technology, a revolutionary new approach to targeting blood-borne diseases by magnetically filtering specific disease-causing components from the bloodstream. The device is being tested for the treatment of Malaria, Sepsis and Leukaemia.

Technology-enabled homecare start-up Cera has raised $17m in Series A funding, just a year and half after launching. 

1. Mindset for start-up sales 
2. Set out the key areas to consider in putting together your first GTM
3. Outlined how to connect with customers as people

Now we’ll hear from the CEO of one of our Portfolio companies – Aimbrain – on how we worked together on GTM and sales strategy that has transformed the way they engage with their customers. The process has helped the company rethink its approach to the core market for its Biometric Identity Platform.

Here, CEO and co-founder Andrius Sutas explains the impact this has had on the business:

TriSpan, a global Private Equity firm, is pleased to announce that Rising Stars, its dedicated restaurant platform, has acquired a majority investment in Rosa’s Thai Cafe, the fast-growing UK-based Thai restaurant group. 

Target Global, a Berlin-based international venture capital fund with $600m assets under management, is launching a dedicated fund to invest in next-generation mobility and transportation.

MiAlgae, a student-launched startup that aims to revolutionise the animal and fish feed industries with microalgae made from the co-products of whisky, has received £500,000 from investors.

The company, founded by Douglas Martin while a masters student at the University of Edinburgh in 2015-16, grows algae rich in omega-3 and other nutrients using co-products from the whisky distillation process.